NCT02696096View on ClinicalTrials.gov

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

PHASE3CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

February 29, 2020

Study Completion Date

February 29, 2020

Conditions

Opioid Addiction

Interventions

OTHER

FMRI

all participants will complete 2 FMRIs

DRUG

Suboxone

all participants will be prescribed Suboxone for 4 months during their study participation

Trial Locations (1)

02906

Butler Hospital, Providence

Sponsors

Lead Sponsor

Butler Hospital

All Listed Sponsors

lead

Butler Hospital

OTHER

NCT02696096 - Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence | Biotech Hunter | Biotech Hunter